- Off Label
- Posts
- 🌱 Cancer Research, Mike Tyson, Autism Benefits
🌱 Cancer Research, Mike Tyson, Autism Benefits
Welcome to Rise & Roll, a bi-weekly newsletter that keeps you smart, savvy, and always in the loop on the latest in cannabis.
Here’s what we have on deck for today…
Medical cannabis gains ground in cancer care
A new study found strong support for medical cannabis as a cancer treatment option.
Researchers analyzed over 10,000 studies and discovered a surprising three-to-one consensus favoring cannabis for managing cancer symptoms.
The research shows cannabis effectively treats cancer-related inflammation, appetite loss, and nausea, opening doors for targeted product development.
This represents a golden opportunity to create specialized formulations for cancer patients while building credibility in the medical community. The growing scientific consensus could help break down remaining barriers to medical cannabis adoption in cancer care.
Mike Tyson takes control as cannabis CEO
Mike Tyson stepped up from brand face to boss, taking over as CEO of Carma HoldCo, the company behind his TYSON 2.0 cannabis brand and other lifestyle products.
This isn't just a title change — Tyson's been hands-on since day one, shaping products and building relationships with retail partners.
For cannabis entrepreneurs, Tyson's move shows how celebrity founders can evolve beyond simple endorsements into operational leaders, potentially creating stronger brand authenticity.
CBD shows promise for autism treatment
CBD cannabis extract may help children and teens with autism, according to new research presented at the 2025 European Congress of Psychiatry.
The study found CBD improved social responsiveness and reduced disruptive behaviors in young people with autism spectrum disorder.
What's exciting is that CBD appeared as safe as placebo, with no increase in adverse events.
While more research is needed, this adds to growing evidence that cannabis compounds can address unmet healthcare needs, creating new markets for innovative products and services targeting specific medical conditions.
If you enjoyed this edition of Rise & Roll, please share it with your friends!
We’ll be back with another edition on Tuesday. See you then!
To stay up-to-date on cannabis news, visit us at riseandroll.news.
What did you think of today's edition |